| Uncontrolled keywords: |
a 54556a, actagardin, agents acting on the eye, ancovenin, antibiotic agent, antifungal agent, bacterial enzyme, bacteriophage lysin, boron derivative, cpl 1, depsipeptide, drug carrier, duramycin, efflux pump inhibitor, epidermin, gallidermin, immunoglobulin G antibody, lacticin 3147, lanthiopeptin, lantibiotic, maleimide, mersacidin, mutacin 1140, natural product, nisin A, parnafungin derivative, polypeptide antibiotic agent, probiotic agent, smap28 peptide, unclassified drug, unindexed drug, antibacterial activity, antibiotic resistance, antifungal activity, bacterial eye infection, bacterial virulence, bacteriophage, Bifidobacterium breve, biomedical engineering, botulism, Candida albicans, chemical modification, conference paper, conformational transition, conjugate, drug potency, drug screening, drug specificity, drug structure, drug synthesis, drug targeting, fungal genome, gene activation, gene inactivation, Gram positive bacterium, human, immunomodulation, infection, intoxication, iron transport, nonhuman, quorum sensing, sequence analysis, signal transduction, single drug dose, Streptomyces, technique, Anti-Bacterial Agents, Antitoxins, Drug Design, Immunologic Factors, Probiotics
|
https://orcid.org/0000-0002-7978-3815
Download Statistics
Download Statistics
